ALGA BIOLOGICS
LIVE

Serial Number

79412399

Owner

Alga Biologics

Attorney

James J. Bitetto

Filing Date

Oct 10, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ALGA BIOLOGICS Trademark

Serial Number: 79412399 • Registration: 8182125

ALGA BIOLOGICS is a trademark filed by Alga Biologics on October 10, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Alga Biologics (2 trademarks)

67 rue du Bouvreuil

Entity Type: 98

Trademark Details

Filing Date

October 10, 2024

Registration Date

March 24, 2026

Published for Opposition

February 3, 2026

Goods & Services

Glycoproteins for industrial use; protein in raw material form for scientific and medical research; recombinant nucleic acid, other than for medical or veterinary purposes; enzymes for industrial use; enzymes for scientific use; enzymes for use in the industrial biotechnology and biopharmaceutical industry; enzymes other than for medical use for marking protein fractions; enzymes derived from biotechnological processes for industrial use; enzymes for protein hydrolysis, other than for medical or veterinary purposes; cell culture media for the biotechnology industry, other than for medical or veterinary purposes; nucleoproteins, other than for medical or veterinary purposes; biochemical products, namely, precursors for in-vitro genetic engineering; biochemical products, namely, monoclonal antibodies for in vitro scientific research use; biochemical preparations for in-vitro and in-vivo scientific use; biochemical preparations, other than for medical or veterinary purposes; plant extracts, other than essential oils, for the manufacture of cosmetics; proteins intended for the manufacture of food; protein in raw material form for manufacturing food for humans; raw proteins for scientific and medical research; raw proteins for use in industry; proteins for use in industry; proteins for the manufacture of cosmetic products; proteins for the food industry; proteins for the manufacture of food supplements; proteins for recombinant DNA techniques, other than for medical or veterinary purposes; chemical reagents, other than for medical or veterinary use

Scientific research; technological research in the field of industrial biotechnology and biopharmaceuticals; engineering services, namely, technical testing in the field of industrial biotechnology and biopharmaceuticals; software development; software design; research and development of new products for third parties in the field of industrial biotechnology and biopharmaceuticals; scientific and technological research services, namely, conducting of technical project studies in the field of industrial biotechnology and biopharmaceuticals; computer system analysis; computer system design; consultant services with respect to computer hardware design and development; software as a service (SaaS) services featuring software for managing, optimizing and monitoring recombinant protein production workflows in microalgae, including digital tracking of strains, culture conditions, expression data and analyses in the field of biotechnology; providing technology information in the field of industrial biotechnology and biopharmaceuticals; design and development of operating software for accessing and using a cloud computing network

Human immunoglobulin for medical use; biotechnological preparations for medical use, namely, antibodies, recombinant proteins, and complex peptides for diagnostics and treatment of cancer and other human diseases; sanitary products, namely, formulation preparations for medical use for medicine; pharmaceutical products for the prevention, diagnostics, and treatment of cancer and other human diseases; veterinary products, namely, recombinant proteins, vaccines, and biologic therapeutics for veterinary use; food supplements; disinfectants; fungicides

Filing History

FINAL DISPOSITION NOTICE SENT TO IB
Aug 31, 2026 FICS
FINAL DISPOSITION PROCESSED
Aug 30, 2026 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 24, 2026 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 4, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 18, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 18, 2026 OPNR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 24, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 24, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 3, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 3, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 28, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 12, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 12, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 12, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 12, 2025 TROA
REFUSAL PROCESSED BY IB
Oct 3, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 16, 2025 RFCS
REFUSAL PROCESSED BY MPU
Sep 16, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 6, 2025 RFCR
NON-FINAL ACTION WRITTEN
Aug 5, 2025 CNRT
ASSIGNED TO EXAMINER
Aug 1, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 31, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 31, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 19, 2024 REPR